Today Hibergene‘s Series B funding round on SyndicateRoom will successfully close at midnight tonight, having raised at least £5,707,336 with the help of over 53 investors. Funds will be used to support R&D activities to launch three new products in 2017. The Irish medical diagnostics company specializes in the urgent diagnosis of potentially fatal human infectious diseases and has developed what it believes to be a simple, easy to use and low cost solution comprising a compact, fully portable, reusable instrument and a menu of proprietary single use molecular tests.